MacroGenics

cash
Biotech

Synaffix, MacroGenics crack open ADC pact, tack on $2.2B to deal

Synaffix and MacroGenics are building off industrywide interest in ADCs, tacking on $2.2 billion and four more targets to an existing collaboration.
Max Bayer Mar 14, 2023 10:30am
Gilead grabs MacroGenics blood-cancer focused bispecific in 176B license-option deal

Gilead offers $1.76B for option to MacroGenics' bispecific

Oct 17, 2022 11:00am
layoff staff workforce

MacroGenics joins biotech layoff wave, slashing 15% of workers

Aug 9, 2022 11:01am
Closed sign in the window of a bar

MacroGenics closes solid tumor clinical trial after 7 people die

Jul 11, 2022 5:51am
Parachute

FDA shores up executive team with 2 hires—Chutes & Ladders

Jul 1, 2022 9:30am
cancer newspaper

MacroGenics switches horses in CD123 race, canning flotetuzumab

Feb 25, 2022 7:30am